SCHEMBL1724947

SCHEMBL1724947

CC(C)(C)OC(=O)N1Cc2cc(OS(=O)(=O)C(F)(F)F)ccc2CC1C(=O)C1CCC(C(N)=O)N1

nearest known ligand 0.44

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
PTPN1 P18031 4/20 0.44
HDAC8 Q9BY41 16/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1725029 0.87 PTPN1 (0.43) PTPN1HDAC8
SCHEMBL1724361 0.84 PTPN1 (0.45) PTPN1HDAC8
SCHEMBL864979 0.81 HDAC8 (0.48) PTPN1HDAC8
SCHEMBL5126474 0.80 PTPN1 (0.67) PTPN1HDAC8
SCHEMBL7743681 0.78 PTPN1 (0.54) PTPN1HDAC8
SCHEMBL7743679 0.78 PTPN1 (0.54) PTPN1HDAC8
SCHEMBL18435172 0.78 PTPN1 (0.47) PTPN1HDAC8
SCHEMBL2083269 0.74 PTPN1 (0.50) PTPN1HDAC8
SCHEMBL864877 0.74 DPP4 (0.50) PTPN1HDAC8
SCHEMBL15630538 0.72 BIRC2 (0.53) PTPN1HDAC8

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2406247-A1 COMPOUNDS FOR THE TREATMENT OF METABOLIC DISORDERS Prosidion Limited (GB) 2012-01-18 EP disclosed
WO-2010103333-A1 COMPOUNDS FOR THE TREATMENT OF METABOLIC DISORDERS PROSIDION LIMITED (GB) 2010-09-16 WO disclosed